Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase IIIb, Efficacy, and Safety Study of Rosuvastatin in Children 10-17 Years of Age With Heterozygous Familial Hypercholesterolemia: a 12-week, Double-blind, Randomized, Multicenter, Placebo-controlled Study With a 40-week, Open-label, Follow-up
Brief Summary: The primary objective of this study is to determine the efficacy of once-daily rosuvastatin in reducing LDL-C in children and adolescents aged 10-17 years with HeFH from baseline (Day 0) to the end of the 12-week double-blind treatment period.


Options:
A: Arm Label: rosuva 5; Type: ACTIVE_COMPARATOR; Interventions: Drug: Rosuvastatin | Arm Label: rosuva 10; Type: ACTIVE_COMPARATOR; Interventions: Drug: Rosuvastatin | Arm Label: rosuva 20; Type: ACTIVE_COMPARATOR; Interventions: Drug: Rosuvastatin | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: rosuva ol; Type: OTHER; Interventions: Drug: Rosuvastatin | Intervention Type: DRUG; Name: Rosuvastatin; Assigned to Arm(s): rosuva 10, rosuva 20, rosuva 5, rosuva ol | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: A; Type: ACTIVE_COMPARATOR; Interventions: Drug: ABT-335, Drug: Atorvastatin | Arm Label: B; Type: ACTIVE_COMPARATOR; Interventions: Drug: ABT-335, Drug: Atorvastatin | Arm Label: C; Type: PLACEBO_COMPARATOR; Interventions: Drug: ABT-335, Drug: Placebo | Arm Label: D; Type: PLACEBO_COMPARATOR; Interventions: Drug: Atorvastatin, Drug: Placebo | Arm Label: E; Type: PLACEBO_COMPARATOR; Interventions: Drug: Atorvastatin, Drug: Placebo | Arm Label: F; Type: PLACEBO_COMPARATOR; Interventions: Drug: Atorvastatin, Drug: Placebo | Intervention Type: DRUG; Name: ABT-335; Assigned to Arm(s): A, B, C | Intervention Type: DRUG; Name: Atorvastatin; Assigned to Arm(s): A, B, D, E, F | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): C, D, E, F
C: Arm Label: A - ABT-143 capsules 5/135 mg; Type: EXPERIMENTAL; Interventions: Drug: ABT-143 | Arm Label: B - ABT-143 capsules 10/135 mg; Type: EXPERIMENTAL; Interventions: Drug: ABT-143 | Arm Label: C - ABT-143 capsules 20/135 mg; Type: EXPERIMENTAL; Interventions: Drug: ABT-143 | Arm Label: D - Simvastatin capsules 40 mg; Type: ACTIVE_COMPARATOR; Interventions: Drug: simvastatin | Intervention Type: DRUG; Name: ABT-143; Assigned to Arm(s): A - ABT-143 capsules 5/135 mg, B - ABT-143 capsules 10/135 mg, C - ABT-143 capsules 20/135 mg | Intervention Type: DRUG; Name: simvastatin; Assigned to Arm(s): D - Simvastatin capsules 40 mg
D: Arm Label: A; Type: ACTIVE_COMPARATOR; Interventions: Drug: ABT-335, Drug: Rosuvastatin Calcium | Arm Label: B; Type: ACTIVE_COMPARATOR; Interventions: Drug: ABT-335, Drug: Rosuvastatin Calcium | Arm Label: C; Type: PLACEBO_COMPARATOR; Interventions: Drug: ABT-335, Drug: Placebo | Arm Label: D; Type: PLACEBO_COMPARATOR; Interventions: Drug: Rosuvastatin Calcium, Drug: Placebo | Arm Label: E; Type: PLACEBO_COMPARATOR; Interventions: Drug: Rosuvastatin Calcium, Drug: Placebo | Arm Label: F; Type: PLACEBO_COMPARATOR; Interventions: Drug: Rosuvastatin Calcium, Drug: Placebo | Intervention Type: DRUG; Name: ABT-335; Assigned to Arm(s): A, B, C | Intervention Type: DRUG; Name: Rosuvastatin Calcium; Assigned to Arm(s): A, B, D, E, F | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): C, D, E, F

Answer: A